Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.40K | -4.06M | -8.49M | -8.97M | -16.35M |
| Total Depreciation and Amortization | 41.10K | 33.50K | 32.70K | 32.30K | 28.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -306.50K | -505.70K | 2.66M | 2.55M | 2.45M |
| Change in Net Operating Assets | -964.30K | -417.20K | 1.08M | 856.50K | 2.01M |
| Cash from Operations | -1.22M | -4.95M | -4.72M | -5.53M | -11.87M |
| Capital Expenditure | -90.10K | -89.30K | -9.20K | -9.20K | -13.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.54M | 4.50M | 4.64M | 3.45M | 13.10M |
| Cash from Investing | 2.45M | 4.41M | 4.63M | 3.44M | 13.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 209.30K | 209.30K | 619.20K | 409.90K | 409.90K |
| Repurchase of Common Stock | -- | -5.30K | -5.30K | -5.30K | -5.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 11.20K | -2.10K | 0.00 |
| Cash from Financing | 209.30K | 204.00K | 625.10K | 402.50K | 404.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.43M | -329.70K | 538.70K | -1.69M | 1.62M |